Prime Minister Narendra Modi has been trying to attract foreign investment with his "Make in India" campaign, but the reality at home was thrown into sharp relief with the news recently that a project to make heart valves in an Indian special economic zone was being stymied because of "pending approvals, delayed clearances and lack of financing options," according to a report by the Economic Times.
Eye diseases have become so prevalent in pets that the number of veterinarians certified in ophthalmology has jumped 33% in the past 5 years to more than 400 in the U.S. alone, according to the American Veterinary Medical Association. Now several animal health companies are answering the call for new products to treat eye diseases, among them France's Ceva Santé Animale.
Intellia Therapeutics, a Novartis-backed biotech working on gene-editing technology, leased a sizable research space in the hotbed of Cambridge, MA.
The U.S. Department of Defense (DOD) has set its sights on developing traumatic brain injury (TBI) technology for a while now, doling out $15 million in contracts in 2014 to a company creating a device for the condition. In its latest move, the DOD is enlisting the University of Michigan for a new project aimed at addressing TBI through med tech.
The United Kingdom's National Health Service sees med tech as crucial to addressing healthcare improvements. It's launched a series of 7 trials with several major technology partners designed to test several means of integrating med tech specifically into at-home care for elderly and chronic disease patients.
With superbug infections proliferating at U.S. healthcare facilities, hospitals are looking for new ways to eliminate potentially deadly bacteria. Mayo Clinic is jumping on the bandwagon, rolling out bacteria-fighting robots that use UV light to kill C. difficile.
Upstart Senseonics expects to be the first to introduce a long-term implant to continuously monitor glucose levels in diabetics. It's already under review for a CE mark after disclosing pivotal European data in October. Now, it's detailed the plans for the pivotal U.S. study of its Eversense Continuous Glucose Monitoring System.
Yu Xue had a hard-earned reputation as a top chemist while she was working for GlaxoSmithKline in its Upper Merion, PA, facility. But Yu Xue--better known as Joyce--was also an accomplished thief during the last four years of her 10-year tenure, according to allegations laid out in a federal indictment filed by the U.S. Attorney's office in Eastern Pennsylvania.
South Korea's Celltrion has recruited Medidata to provide eClinical technology as it works to develop copycat versions of the world's top-selling biological treatments.
GlaxoSmithKline and Qualcomm are in talks to create a joint venture to enable GSK to expand into med tech, according to a report by Bloomberg that cites anonymous people knowledgeable of the matter.